Bioalpha in vaccine distribution MoU


BurIn a filing with Bursa Malaysia, it said the contract was effective since Jan 22, and subject to approval from the relevant authorities for the distribution and sale of the vaccine.

KUALA LUMPUR: Bioalpha Holdings Bhd’s subsidiary has entered a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for the import and distribution of the Covid-19 vaccine in Malaysia.

In a filing with Bursa Malaysia, it said the contract was effective since Jan 22, and subject to approval from the relevant authorities for the distribution and sale of the vaccine.

“The MoU enables the company to expand its business into distribution of vaccines, such as Covid-19 vaccine, which has favourable prospects following the recent pandemic, ” said the health supplement company.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Bioalpha , vaccine , distribution , Zuellig Pharma ,

   

Did you find this article insightful?

Yes
No

67% readers found this article insightful

Next In Business News

CIMB sees less provisions in 2021 after coronavirus-hit 2020
FBM KLCI pares losses but still in red
Petronas records net profit of RM10.5b for FY20 excluding impairments
Hong Leong Bank records higher operating profit in 2Q
Bintulu Port's net profit falls to RM93.3mil in FY20
MAHB records 4Q net loss of RM685.02mil
Guan Chong's FY20 net profit increases to RM223.19mil
SC launches capital market green financing series
FGV records highest positive financial performance in 5 yrs
RHB posts FY20 net profit of RM2.03bil, proposes div of 7.65 sen/share

Stories You'll Enjoy


Vouchers